<?xml version="1.0" encoding="UTF-8"?>
<p>We used 1646 whole genome HIV-1 samples from subtypes B, C, F1 and CRF01_AE and recombinant forms between these subtypes (Table A in 
 <ext-link ext-link-type="uri" xlink:href="http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.115.024208/-/DC1/FileS1.pdf" xmlns:xlink="http://www.w3.org/1999/xlink">File S1</ext-link>). We used the subset of genomes from China sequenced between 2005 and 2009 (297 sequences; Table B in 
 <ext-link ext-link-type="uri" xlink:href="http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.115.024208/-/DC1/FileS1.pdf" xmlns:xlink="http://www.w3.org/1999/xlink">File S1</ext-link>). For the study in South America (Brazil and Argentina), we used data available between 1999 and 2005 (128 sequences; Table C in 
 <ext-link ext-link-type="uri" xlink:href="http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.115.024208/-/DC1/FileS1.pdf" xmlns:xlink="http://www.w3.org/1999/xlink">File S1</ext-link>). Finally, for the worldwide PCA analysis, we used all 1646 genomes available.
</p>
